Posted by Michael Wonder on 16 Aug 2021
Abbott's Amplatzer Amulet device approved by FDA to treat people with atrial fibrillation at risk of stroke
16 August 2021 - Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation.
Abbott today announced that the U.S. FDA approved the company's Amplatzer Amulet left atrial appendage occluder to treat people with atrial fibrillation who are at risk of ischaemic stroke.
The device offers immediate closure of the left atrial appendage – an area where blood clots can form in people suffering from atrial fibrillation – reducing their risk of stroke and immediately eliminating the need for blood-thinning medication.
